Search results

From Proteopedia

You searched for Immunogen

Jump to: navigation, search

There is no page with the exact title "Immunogen". The search results for "Immunogen" are displayed below. You can create a page titled Immunogen (by clicking on the red link).

For more information about searching Proteopedia, see Help.

Showing below up to 20 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Immunogen (40 bytes)
    1: List of pages with the keyword Immunogen
  2. Category:Designed immunogen (49 bytes)
    1: List of pages with the keyword Designed immunogen
  3. Category:Immunogen design (47 bytes)
    1: List of pages with the keyword Immunogen design
  4. Category:Germline-targeting immunogen (59 bytes)
    1: List of pages with the keyword Germline-targeting immunogen
  5. Category:Malaria immunogen design rosetta pross (69 bytes)
    1: List of pages with the keyword Malaria immunogen design rosetta pross
  6. Category:Pfemp1 epcr vaccine immunogen (60 bytes)
    1: ...ist of pages with the keyword Pfemp1 epcr vaccine immunogen
  7. Category:Nanoparticle immunogen (53 bytes)
    1: List of pages with the keyword Nanoparticle immunogen

Page text matches

  1. 1o75 (3,969 bytes)
    11: ...EPA] This antigen is a pathogen-specific membrane immunogen. Most abundant of the membrane lipoproteins, only...
  2. 1u8h (4,798 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  3. 1u8i (4,796 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  4. 1u8j (4,799 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  5. 1u8l (4,798 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  6. 1u8m (4,798 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  7. 1u8n (4,799 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  8. 1u8o (4,799 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  9. 1u8p (4,799 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  10. 1u8q (4,799 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  11. 1u91 (4,821 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  12. 1u92 (4,821 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  13. 1u93 (4,821 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  14. 1u95 (4,799 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  15. 2f5a (4,400 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  16. 2f5b (5,742 bytes)
    23: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  17. 2pw1 (4,536 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  18. 2pw2 (4,537 bytes)
    21: ...her problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence varia...
  19. 8f38 (3,899 bytes)
    13: ...h integrates wild-type HA sequences into a single immunogen to expand the breadth of accessible antibody epit...
  20. 4gaj (4,006 bytes)
    13: ...ope provide a starting point for the design of an immunogen capable of eliciting AP33-like antibodies.

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

List redirects
Search for
Views
Personal tools